home / stock / krro / krro news


KRRO News and Press, Korro Bio Inc. From 01/28/26

Stock Information

Company Name: Korro Bio Inc.
Stock Symbol: KRRO
Market: NASDAQ
Website: frequencytx.com

Menu

KRRO KRRO Quote KRRO Short KRRO News KRRO Articles KRRO Message Board
Get KRRO Alerts

News, Short Squeeze, Breakout and More Instantly...

KRRO - KRRO Price Target Alert: $30.00. Issued by Piper Sandler

2026-01-28 19:04:40 ET Yasmeen Rahimi from Piper Sandler issued a price target of $30.00 for KRRO on 2026-01-28 23:12:24. The adjusted price target was set to $30.00. At the time of the announcement, KRRO was trading at $11.69. The overall price target consensus is at $1...

KRRO - Overweight Recommendation Issued On KRRO By Piper Sandler

2026-01-28 18:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for KRRO on January 28, 2026 11:12PM ET. The previous analyst recommendation was Overweight. KRRO was trading at $11.69 at issue of the analyst recommendation. The overall analyst consensus : H...

KRRO - KRRO Price Target Alert: $22.00. Issued by Oppenheimer

2026-01-28 07:04:52 ET from Oppenheimer issued a price target of $22.00 for KRRO on 2026-01-28 11:54:16. The adjusted price target was set to $22.00. At the time of the announcement, KRRO was trading at $10.74. The overall price target consensus is at $21.00 with high pr...

KRRO - Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-20 11:46:00 ET Korro Bio, Inc. (KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST... Read the full article on Seeking Alpha For further details see: Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transc...

KRRO - Korro to Host Virtual Analyst Day on January 27, 2026

- Program to feature presentations from the company management about  KRRO-121 for the potential treatment of hyperammonemia , a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle disorder - CAMBRIDGE, Mass., Jan....

KRRO - Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44 th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:30 a.m. PT (1:30 p.m. E...

KRRO - US Companies Moving the Markets, Morning edition
Fri, Nov 14, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Nuvve Holding Corp. (NVVE) rose 204.6% to $0.4758 on volume of 1,404,137,354 shares TNL Mediagene (TNMG) rose 37.2% to $0.411 on volume of 456,185,783 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 10.1% to $3.83 on volu...

KRRO - US Companies Moving the Markets, Evening edition
Thu, Nov 13, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Nuvve Holding Corp. (NVVE) rose 206.6% to $0.47885 on volume of 1,275,854,526 shares TNL Mediagene (TNMG) rose 39.4% to $0.4176 on volume of 442,607,068 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 12.0% to $3.8987 on ...

KRRO - Korro Bio GAAP EPS of -$1.92, revenue of $1M

2025-11-13 12:25:43 ET More on Korro Bio Korro Bio stock fell after missing expectations in early stage KRRO-110 trial Seeking Alpha’s Quant Rating on Korro Bio Historical earnings data for Korro Bio Financial information for Korro Bio Read t...

KRRO - Korro Bio stock fell after missing expectations in early stage KRRO-110 trial

2025-11-13 09:49:43 ET More on Korro Bio Seeking Alpha’s Quant Rating on Korro Bio Historical earnings data for Korro Bio Financial information for Korro Bio Read the full article on Seeking Alpha For further details see: Korro Bio stock fe...

Previous 10 Next 10